Menu
Enrolling by invitation NCT05656768

Sleep and Circadian Contributions to Nighttime Blood Pressure

No phase Interventional Sleep Circadian Rhythm Blood Pressure Hypertension

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Constant Routine Protocol.
Who it may be relevant to
Registry conditions: Sleep, Circadian Rhythm, Blood Pressure, Hypertension. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

Broadly, this study (SCN-BP) seeks to examine sleep and circadian factors that contribute to blood pressure levels at night.

Detailed description

SCN-BP is imbedded in a parent grant titled "Improving the Detection of Hypertension (IDH-MEGA)" and examines a variety of sleep (e.g., sleep duration, timing, and the presence of sleep disorder) and circadian factors in Aims 1 and 2. In Aim 3, the investigators will conduct a 30-hour constant routine protocol to directly examine endogenous circadian and blood pressure rhythms. Aims 1 and 2 are purely observation. The study design design described below pertains the intervention piece of this study (Aim 3).

Interventions

  • Other Constant Routine Protocol
    A constant routine protocol is used to directly examine markers of circadian rhythmicity (e.g., melatonin and core body temperature). A constant routine protocol requires an individual to remain in a dimly lit room, in a constant semi-recumbent posture, and remain awake for more than 24 hours. It is one of two gold-standard research protocols for examining circadian rhythms in humans.

Primary outcome measures

  • Change in Melatonin [Time frame: Hourly samples obtained over 30 hours]
  • Change in Core body temperature [Time frame: Continuous measurements over 30 hours]
Secondary outcome measures (1)
  • Change in Blood pressure [Time frame: Measurements obtained every 30 minutes over 30 hours]

Eligibility criteria

Inclusion criteria

  • Participant in the parent grant (IDH-MEGA)

Exclusion criteria

\-

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Other

Study locations

United States · 1 center
  • University of Alabama at Birmingham — Birmingham

Identifiers

NCT: NCT05656768 · IRB-300010042

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗